Jan 9 2007, 7:00 AM EST
MARKETWIRE
OmniComm Systems, Inc. (OTCBB: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that it will partner with Capital Technology Information Services, Inc. (CTIS) to form an integration initiative between OmniComm's TrialMaster(R) and CTIS' proprietary healthcare informatics framework called Trial Bridge(TM) that supports the largest research organization in the world. The partnership unites OmniComm's First in Functionality(TM) EDC system, a feature and function rich Electronic Data Capture (EDC) solution for clinical trial data management, with CTIS' Trial Bridge(TM) framework, currently utilized by CTIS in providing comprehensive clinical trials informatics support to the largest Institutes at the National Institute of Health (NIH) including the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Disease (NIAID) for the past fifteen years.
CTIS addresses the business and regulatory requirements of drug development and testing from pre-clinical to IND filing to NDA submission. Their unparalleled industry experience encompasses 850,000 patients, 100,000 documents, 25,000 physicians, 9,000 sites, 1,000 drug agents and 10,000 protocols. The Trial Bridge framework provides a central point that connects networks, sites and PIs allowing Sponsors and CROs better access and management of all trial related data. The Trial Bridge framework includes numerous components including eProtocol development, IRB management, investigator administration, enrollment, tracking, reporting and safety management of adverse events (AEs) all integrated and presented in an executive dashboard providing vital signs management at all levels.
"CTIS is committed to patient well-being by utilizing Internet based solutions that improve the quality, efficiency and safety of clinical trials resulting in improved outcomes management and increased Return on Investment (ROI)," said Raj Shah, Chairman and CEO of Capital Technology Information Services, Inc., a Capital Surini Group International, Inc. Company.
TrialMaster offers unrivaled freedom to conduct clinical trials, with unparalleled flexibility, ease-of-use and complete control over clinical data. TrialMaster employs forward-looking technology based on a Service Oriented Architecture (SOA) with an underlying Microsoft(R) .NET architecture, providing a simple "drag and drop" design tool that doesn't require any programming. With a clean user-friendly and intuitive GUI based on a logical build process that allows easy, rapid trial development and deployment, TrialMaster allows research organizations to capitalize on EDC their way. With LogiXML Ad-Hoc reporting fully integrated to the solution users enjoy completely interactive point-and-click access to all of their trial data. On-demand importing of CDISC, HL7, core labs and patient diary data is built in and the sophisticated export features in TrialMaster includes output to client systems in SAS, CDISC, CSV, TAB and XML formats. In a market overview titled "The Promise of Next-Gen eClinical Trial Software" by Forrester Research, OmniComm was given the highest rating among its competitors for industry middleware.
"The depth of experience that CTIS brings to our partnership in the government sector is unmatched in the clinical trial market space," said Cornelis Wit, President and CEO of OmniComm. "This partnership with OmniComm integrates CTIS' government experience with our proven track record in the commercial EDC market creating a first of its kind offering."
About CTIS
CTIS is a Rockville, Maryland
ADVERTISEMENT
INTERVIEW:
NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates
...MORE
NewsArticles BlogsADVERTISEMENT
Subscribe to RSS
Email
Print
Share
More News
Listen
Save
Comment
View All